The plague that began in Ethiopia and passed through Egypt and Libya to Greece in 430-426 B.C. changed the balance of power between Athens and Sparta, ending the Golden Age of Pericles and Athenian dominance in the ancient world. It is thought that up to one third of the Athenians, including their charismatic leader, Pericles, perished in the epidemic.
Until now our understanding of this outbreak was based on the account by the fifth century B.C. Greek historian Thucydides, who himself was taken ill with the plague but recovered. Despite Thucydides' detailed description, researchers have not managed to agree on the identity of the plague and several diseases, including bubonic plague, smallpox, anthrax and measles have been implicated in the emergence and spread of this epidemic.
A mass burial pit unearthed in the Kerameikos ancient cemetery of Athens and dated back to the time of the historical outbreak, provided the required skeletal material for the investigation of ancient microbial DNA. Aided by modern DNA recovery and amplification techniques, Papagigorakis et al used dental pulp to identify DNA sequences similar to those of the modern day Salmonella enterica serovar Typhi, the organism that causes typhoid fever. The results of this study point to typhoid fever as the probable cause of the Plague of Athens.
Typhoid fever is transmitted by contaminated food or water, and nowadays the disease is most common in developing countries and in travellers returning from these countries.
Corresponding author Dr Manolis J Papagrigorakis of the University of Athens says: "Studying the historical aspects of infectious diseases can be a powerful tool for several disciplines to learn from. We believe this report to be of outstanding importance for many scientific fields, since it sheds light to one of the most debated enigmas in medical history."
The International Journal of Infectious Diseases
The International Journal of Infectious Diseases (IJID) is published by Elsevier on behalf of the International Society for Infectious Diseases www.isid.org on a bi-monthly basis. The Journal aims to provide a source of information relevant to professionals involved in the epidemiology, clinical diagnosis, treatment and control of infectious diseases with particular emphasis placed on those disease which are most common in less-developed countries.
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier's 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, such as ScienceDirect (http://www.sciencedirect.com/), MD Consult (http://www.mdconsult.com/), Scopus (http://www.info.scopus.com/), bibliographic databases, and online reference works.
Elsevier (http://www.elsevier.com/) is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group plc (http://www.reedelsevier.com/), a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Last reviewed: By John M. Grohol, Psy.D. on 21 Feb 2009
Published on PsychCentral.com. All rights reserved.